Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Virol ; 88(21): 12703-14, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-25142608

RESUMO

UNLABELLED: Infections with Marburg virus (MARV) and Ebola virus (EBOV) cause severe hemorrhagic fever in humans and nonhuman primates (NHPs) with fatality rates up to 90%. A number of experimental vaccine and treatment platforms have previously been shown to be protective against EBOV infection. However, the rate of development for prophylactics and therapeutics against MARV has been lower in comparison, possibly because a small-animal model is not widely available. Here we report the development of a mouse model for studying the pathogenesis of MARV Angola (MARV/Ang), the most virulent strain of MARV. Infection with the wild-type virus does not cause disease in mice, but the adapted virus (MARV/Ang-MA) recovered from liver homogenates after 24 serial passages in severe combined immunodeficient (SCID) mice caused severe disease when administered intranasally (i.n.) or intraperitoneally (i.p.). The median lethal dose (LD50) was determined to be 0.015 50% TCID50 (tissue culture infective dose) of MARV/Ang-MA in SCID mice, and i.p. infection at a dose of 1,000× LD50 resulted in death between 6 and 8 days postinfection in SCID mice. Similar results were obtained with immunocompetent BALB/c and C57BL/6 mice challenged i.p. with 2,000× LD50 of MARV/Ang-MA. Virological and pathological analyses of MARV/Ang-MA-infected BALB/c mice revealed that the associated pathology was reminiscent of observations made in NHPs with MARV/Ang. MARV/Ang-MA-infected mice showed most of the clinical hallmarks observed with Marburg hemorrhagic fever, including lymphopenia, thrombocytopenia, marked liver damage, and uncontrolled viremia. Virus titers reached 10(8) TCID50/ml in the blood and between 10(6) and 10(10) TCID50/g tissue in the intestines, kidney, lungs, brain, spleen, and liver. This model provides an important tool to screen candidate vaccines and therapeutics against MARV infections. IMPORTANCE: The Angola strain of Marburg virus (MARV/Ang) was responsible for the largest outbreak ever documented for Marburg viruses. With a 90% fatality rate, it is similar to Ebola virus, which makes it one of the most lethal viruses known to humans. There are currently no approved interventions for Marburg virus, in part because a small-animal model that is vulnerable to MARV/Ang infection is not available to screen and test potential vaccines and therapeutics in a quick and economical manner. To address this need, we have adapted MARV/Ang so that it causes illness in mice resulting in death. The signs of disease in these mice are reminiscent of wild-type MARV/Ang infections in humans and nonhuman primates. We believe that this will be of help in accelerating the development of life-saving measures against Marburg virus infections.


Assuntos
Modelos Animais de Doenças , Infecções por Filoviridae/patologia , Infecções por Filoviridae/virologia , Filoviridae/crescimento & desenvolvimento , Adaptação Biológica , Animais , Sangue/virologia , Filoviridae/genética , Filoviridae/isolamento & purificação , Dose Letal Mediana , Fígado/virologia , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C57BL , Camundongos SCID , Dados de Sequência Molecular , RNA Viral/genética , Análise de Sequência de DNA , Inoculações Seriadas , Análise de Sobrevida , Carga Viral
2.
J Virol Methods ; 193(2): 565-71, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-23748121

RESUMO

Two common methods of quantifying filovirus infectivity, a plaque assay and 50% cell culture infectious dose (TCID50) endpoint dilution assay, were compared. The two assays were performed side by side using the same virus stock sample to determine the correlation between the results of the two assays. The TCID50 assay appeared to be more sensitive but slightly more variable, and there was a tenfold difference in the numerical results of these methods of enumeration. The advantages and disadvantages of both assays are discussed. Both methods are useful and practicable in filovirus research, and this comparison will be hugely beneficial to the filovirus research community as it seeks to become more united. Further work in this area should be performed to ensure consistency in filovirus research.


Assuntos
Filoviridae/fisiologia , Viabilidade Microbiana , Carga Viral/métodos , Ensaio de Placa Viral/métodos , Animais , Chlorocebus aethiops , Filoviridae/crescimento & desenvolvimento , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Células Vero , Cultura de Vírus/métodos
3.
PLoS Pathog ; 7(1): e1001258, 2011 Jan 06.
Artigo em Inglês | MEDLINE | ID: mdl-21253575

RESUMO

Interferon-inducible transmembrane proteins 1, 2, and 3 (IFITM1, 2, and 3) are recently identified viral restriction factors that inhibit infection mediated by the influenza A virus (IAV) hemagglutinin (HA) protein. Here we show that IFITM proteins restricted infection mediated by the entry glycoproteins (GP(1,2)) of Marburg and Ebola filoviruses (MARV, EBOV). Consistent with these observations, interferon-ß specifically restricted filovirus and IAV entry processes. IFITM proteins also inhibited replication of infectious MARV and EBOV. We observed distinct patterns of IFITM-mediated restriction: compared with IAV, the entry processes of MARV and EBOV were less restricted by IFITM3, but more restricted by IFITM1. Moreover, murine Ifitm5 and 6 did not restrict IAV, but efficiently inhibited filovirus entry. We further demonstrate that replication of infectious SARS coronavirus (SARS-CoV) and entry mediated by the SARS-CoV spike (S) protein are restricted by IFITM proteins. The profile of IFITM-mediated restriction of SARS-CoV was more similar to that of filoviruses than to IAV. Trypsin treatment of receptor-associated SARS-CoV pseudovirions, which bypasses their dependence on lysosomal cathepsin L, also bypassed IFITM-mediated restriction. However, IFITM proteins did not reduce cellular cathepsin activity or limit access of virions to acidic intracellular compartments. Our data indicate that IFITM-mediated restriction is localized to a late stage in the endocytic pathway. They further show that IFITM proteins differentially restrict the entry of a broad range of enveloped viruses, and modulate cellular tropism independently of viral receptor expression.


Assuntos
Antígenos de Diferenciação/metabolismo , Filoviridae/patogenicidade , Vírus da Influenza A/patogenicidade , Coronavírus Relacionado à Síndrome Respiratória Aguda Grave/patogenicidade , Viroses/virologia , Internalização do Vírus , Animais , Antígenos de Diferenciação/imunologia , Linhagem Celular Tumoral , Chlorocebus aethiops , Endotélio Vascular , Feminino , Filoviridae/crescimento & desenvolvimento , Interações Hospedeiro-Patógeno , Humanos , Vírus da Influenza A/crescimento & desenvolvimento , Camundongos , Coronavírus Relacionado à Síndrome Respiratória Aguda Grave/crescimento & desenvolvimento , Células Vero , Viroses/imunologia , Viroses/metabolismo , Replicação Viral
4.
Proc Natl Acad Sci U S A ; 106(8): 2886-91, 2009 Feb 24.
Artigo em Inglês | MEDLINE | ID: mdl-19179289

RESUMO

Mammalian cells employ numerous innate cellular mechanisms to inhibit viral replication and spread. Tetherin, also known as Bst-2 or CD317, is a recently identified, IFN-induced, cellular response factor that blocks release of HIV-1 and other retroviruses from infected cells. The means by which tetherin retains retroviruses on the cell surface, as well as the mechanism used by the HIV-1 accessory protein Vpu to antagonize tetherin function and promote HIV-1 release, are unknown. Here, we document that tetherin functions as a broadly acting antiviral factor by demonstrating that both human and murine tetherin potently inhibit the release of the filovirus, Ebola, from the surface of cells. Expression of the Ebola glycoprotein (GP) antagonized the antiviral effect of human and murine tetherin and facilitated budding of Ebola particles, as did the HIV-1 Vpu protein. Conversely, Ebola GP could substitute for Vpu to promote HIV-1 virion release from tetherin-expressing cells, demonstrating a common cellular target for these divergent viral proteins. Ebola GP efficiently coimmunoprecipitated with tetherin, suggesting that the viral glycoprotein directly interferes with this host antiviral factor. These results demonstrate that tetherin is a cellular antiviral factor that restricts budding of structurally diverse enveloped viruses. Additionally, Ebola has evolved a highly effective strategy to combat this antiviral response elicited in the host during infection.


Assuntos
Antígenos CD/fisiologia , Ebolavirus/fisiologia , Filoviridae/fisiologia , Glicoproteínas/fisiologia , Glicoproteínas de Membrana/fisiologia , Proteínas Virais/fisiologia , Animais , Antígenos CD/metabolismo , Linhagem Celular , Ensaio de Imunoadsorção Enzimática , Filoviridae/crescimento & desenvolvimento , Proteínas Ligadas por GPI , Glicoproteínas/metabolismo , Humanos , Glicoproteínas de Membrana/metabolismo , Camundongos , Microscopia Eletrônica de Varredura , Ligação Proteica , Proteínas Virais/metabolismo
5.
Cell Microbiol ; 9(4): 962-76, 2007 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-17381429

RESUMO

Understanding how protective innate immune responses are generated is crucial to defeating highly lethal emerging pathogens. Accumulating evidence suggests that potent innate immune responses are tightly linked to control of Ebola and Marburg filoviral infections. Here, we report that unlike authentic or inactivated Ebola and Marburg, filovirus-derived virus-like particles directly activated human natural killer (NK) cells in vitro, evidenced by pro-inflammatory cytokine production and enhanced cytolysis of permissive target cells. Further, we observed perforin- and CD95L-mediated cytolysis of filovirus-infected human dendritic cells (DCs), primary targets of filovirus infection, by autologous NK cells. Gene expression knock-down studies directly linked NK cell lysis of infected DCs to upregulation of the natural cytotoxicity receptor, NKp30. These results are the first to propose a role for NK cells in the clearance of infected DCs and the potential involvement of NKp30-mediated cytolysis in control of viral infection in vivo. Further elucidation of the biology of NK cell activation, specifically natural cytotoxicity receptors like NKp30 and NKp46, promises to aid our understanding of microbial pathology.


Assuntos
Células Dendríticas/metabolismo , Filoviridae/crescimento & desenvolvimento , Receptores Imunológicos/fisiologia , Morte Celular/genética , Morte Celular/fisiologia , Células Cultivadas , Citocinas/metabolismo , Citotoxicidade Imunológica/imunologia , Células Dendríticas/imunologia , Células Dendríticas/virologia , Proteína Ligante Fas/metabolismo , Citometria de Fluxo , Humanos , Células K562 , Células Matadoras Naturais/imunologia , Células Matadoras Naturais/metabolismo , Glicoproteínas de Membrana/metabolismo , Mutação , Receptor 1 Desencadeador da Citotoxicidade Natural , Receptor 2 Desencadeador da Citotoxicidade Natural , Receptor 3 Desencadeador da Citotoxicidade Natural , Perforina , Proteínas Citotóxicas Formadoras de Poros/metabolismo , Receptores Imunológicos/genética , Receptores Imunológicos/metabolismo , Vírion/crescimento & desenvolvimento
6.
Vestn Ross Akad Med Nauk ; (2): 26-30, 2005.
Artigo em Russo | MEDLINE | ID: mdl-15776963

RESUMO

The purpose of the study was to investigate, in the Vero cell culture, the antiviral activity of vegetable tritrpens derivatives and ribavirin analogues against the viruses of measles, herpes simple (type 1), cytomegaloviruses and filoviruses. The toxicity and antiviral activity of compounds were determined after coloring of cells with crystal violate. Additionally, the combined action of triterpens' derivatives and ribavirin was investigated. The studied compounds showed relatively low antiviral activity, nonetheless, further research of vegetable triterpens and their derivatives as well as ribavirin analogues would be promising.


Assuntos
Antivirais/farmacologia , Citomegalovirus/efeitos dos fármacos , Filoviridae/efeitos dos fármacos , Herpesvirus Humano 1/efeitos dos fármacos , Morbillivirus/efeitos dos fármacos , Ribavirina/farmacologia , Triterpenos/farmacologia , Animais , Chlorocebus aethiops , Colorimetria , Citomegalovirus/crescimento & desenvolvimento , Filoviridae/crescimento & desenvolvimento , Herpesvirus Humano 1/crescimento & desenvolvimento , Humanos , Técnicas In Vitro , Pulmão/embriologia , Morbillivirus/crescimento & desenvolvimento , Células Vero
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...